愛玩股
English
基本資料
相對強度
財報分析
成長能力
財務比率
現金流量
償債能力
成本分析
實用連結
雅虎財經
公司簡介
研究報告
在外流通股數
歷史市銷率
歷史本益比
盈餘估計修正
存貨周轉率
應收帳款周轉率
內部人交易
新聞
NeuroSense Therapeutics Ltd. Warrant (
NRSNW
) - Nasdaq
Discover real-time NeuroSense Therapeutics Ltd. Warrant (
NRSNW
)
stock
prices, quotes, historical data, news, and Insights for informed trading and ...
NRSNW
: NeuroSense Therapeutics Equity Warrant Exp 9th ...
Get NeuroSense Therapeutics Equity Warrant Exp 9th Nov 2026 (
NRSNW
:NASDAQ) real-time
stock
quotes, news, price and financial information from CNBC.
NRSNW
(NeuroSense Therapeutics Ltd. Warrant)
Stock
Info
NRSNW
○ NeuroSense Therapeutics Ltd. Warrant ○ Nasdaq. Market Cap (USD), 26.2M. PE, -. EPS, -. Dividend Yield, -. 5 days: -, 20 days: -, 60 days: ...
NeuroSense Therapeutics Ltd. - Warrant (
NRSNW
)
Stock
...
$0.3100 ;
NRSNW
is UP 297% since the begininning of the year ;
NRSNW
is DOWN -13% BELOW 20 day SMA ;
NRSNW
is UP 24% ABOVE 200 day SMA ...
Neurosense Therapeutics Ltd WT (
NRSNW
)
Stock
Analysis
NRSNW
Price, Volume, Earnings, and Dividend Date · Last Price$0.29 · Previous Close$0.29 · Change $0.00 · Open$0.26 · Volume1,049 · Avg. Volume (100-day)10,326 ...
Home - Neurosense
NeuroSense Therapeutics is a clinical-stage drug development company, advancing a groundbreaking treatment for people living with ALS, as well as other ...
What is NeuroSense Therapeutics Current Valuation?
The intrinsic value of NeuroSense Therapeutics'
stock
can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or ...
Best Performing
Stock
February 2023 | StatMuse Money
...
NRSNW
. ASSET, MONTH, % RETURN. Arrowroot Acquisition (ARRWW), February 2023, 736.75%. Enlight Renewable Energy Ltd Ordinary Shares (ENLT), February 2023, 525.77 ...
免責聲明
本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。